Crinetics Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $861.80 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $861.80M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $431.20M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $311.30M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $254.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $861.80M 10-K · filed 2026-02-26 |
| 2024-12-31 | $431.20M 10-K · filed 2025-02-27 |
| 2023-12-31 | $311.30M 10-K · filed 2024-02-28 |
| 2022-12-31 | $254.50M 10-K · filed 2023-02-28 |
| 2021-12-31 | $209.40M 10-K · filed 2022-03-30 |
| 2020-12-31 | $118.20M 10-K · filed 2021-03-30 |
| 2019-12-31 | $54.50M 10-K · filed 2020-03-09 |
| 2018-12-31 | $8.70M 10-K · filed 2019-03-13 |